#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombocytopenia Epilepsy Cystic fibrosis respiratory infection suppression Rectal cancer Leukaemia Bronchopulmonary dysplasia Antiphospholipid antibodies Phenylketonuria Red blood cell abnormality Hidradenitis Vernal keratoconjunctivitis Vulval cancer Chronic graft versus host disease in skin Primary mediastinal large B-cell lymphoma Follicular lymphoma stage II More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Life with Disease Haemophilia B with anti factor IX – Treatment Noonan syndrome – Trials in Disease Hypereosinophilic syndrome Amyotrophic lateral sclerosis – Treatment Sarcoma – Treatment Kearns-Sayre syndrome – Trials in Disease Erdheim-Chester disease – Treatment Basal cell naevus syndrome Mitochondrial myopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Heparin Dydrogesterone Etidronate Disodium Resiquimod Sulfate Art6043 Elamipretide Trihydrochloride Calcium Folinate Pentahydrate Clioquinol Zamtocabtagene Autoleucel Mesalazine Cendakimab Exenatide ULIXERTINIB Molidustat Sodium Siplizumab Adenosine Gallium (68Ga) Psma-R2 Inotuzumab Ozogamicin Izorlisib Mesilate Indometacin Ph. Eur. More therapies…

    Learn about Your Condition

    Naevus flammeus Muscle spasticity Retinopathy proliferative Aortic aneurysm Burkitt's lymphoma Chronic hepatitis C Patent ductus arteriosus Cerebral amyloid angiopathy Extra-osseous Ewing's sarcoma Primary hyperthyroidism Ocular hypertension Oesophagogastroscopy Pain in extremity Osteogenesis imperfecta Acute cardiac event More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Bulgaria Czechia Denmark Finland France Germany +8

  • A Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Azd5004
    • Semaglutide
    Bulgaria Germany Hungary Italy Poland

  • Study comparing two forms of cagrilintide with placebo for weight loss in adults with overweight or obesity

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Cagrilintide
    Greece Hungary Portugal Sweden

  • Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial

    Recruiting

    3 1
    Investigated Diseases:
    • Huntington’s disease
    Investigated Drugs:
    • VOTOPLAM
    Austria Belgium Bulgaria Czechia Denmark Finland +14

  • Phase 1b-2 Study of Safety and Preliminary Efficacy of LRK-4189 Alone or with Drug Combination in Patients with Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan
    France

  • Study of PF-08653945 Bioavailability After Subcutaneous Injection in the Thigh, Upper Arm, or Abdomen in Adults with Obesity

    Recruiting

    1 1 1
    Investigated Diseases:
    • Overweight
    Belgium
Previous Page
1 … 637 638 639 640 641 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!